These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 29440279)
21. Upregulation of miR-181a impairs lipid metabolism by targeting PPARα expression in nonalcoholic fatty liver disease. Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790 [TBL] [Abstract][Full Text] [Related]
22. Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis. Cheng R; Ding L; He X; Takahashi Y; Ma JX Diabetes; 2016 Dec; 65(12):3730-3743. PubMed ID: 27543085 [TBL] [Abstract][Full Text] [Related]
23. Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis. Gui Y; Wang Y; Palanza Z; Wang JL; Gupta P; Tao J; Qiao Y; Hargis G; Kreutzer DL; Bastacky SI; Yu Y; Wang Y; Liu S; Fu H; Zhou D Mol Metab; 2023 May; 71():101712. PubMed ID: 36963615 [TBL] [Abstract][Full Text] [Related]
24. Thioredoxin-interacting protein regulates lipid metabolism via Akt/mTOR pathway in diabetic kidney disease. Du C; Wu M; Liu H; Ren Y; Du Y; Wu H; Wei J; Liu C; Yao F; Wang H; Zhu Y; Duan H; Shi Y Int J Biochem Cell Biol; 2016 Oct; 79():1-13. PubMed ID: 27497988 [TBL] [Abstract][Full Text] [Related]
25. Constitutive regulation of cardiac fatty acid metabolism through peroxisome proliferator-activated receptor alpha associated with age-dependent cardiac toxicity. Watanabe K; Fujii H; Takahashi T; Kodama M; Aizawa Y; Ohta Y; Ono T; Hasegawa G; Naito M; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T J Biol Chem; 2000 Jul; 275(29):22293-9. PubMed ID: 10801788 [TBL] [Abstract][Full Text] [Related]
27. Huangkui capsule, an extract from Abelmoschus manihot (L.) medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-α/γ and attenuating endoplasmic reticulum stress in rats. Ge J; Miao JJ; Sun XY; Yu JY J Ethnopharmacol; 2016 Aug; 189():238-49. PubMed ID: 27224243 [TBL] [Abstract][Full Text] [Related]
28. Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease. Guo X; Wen S; Wang J; Zeng X; Yu H; Chen Y; Zhu X; Xu L Phytomedicine; 2024 Jul; 130():155705. PubMed ID: 38761776 [TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor α-dependent renoprotection of murine kidney by irbesartan. Harada M; Kamijo Y; Nakajima T; Hashimoto K; Yamada Y; Shimojo H; Gonzalez FJ; Aoyama T Clin Sci (Lond); 2016 Nov; 130(21):1969-1981. PubMed ID: 27496805 [TBL] [Abstract][Full Text] [Related]
30. Decreased longevity and enhancement of age-dependent lesions in mice lacking the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha). Howroyd P; Swanson C; Dunn C; Cattley RC; Corton JC Toxicol Pathol; 2004; 32(5):591-9. PubMed ID: 15603543 [TBL] [Abstract][Full Text] [Related]
31. Study on the Mechanism of Estrogen Regulating Endometrial Fibrosis After Mechanical Injury Via MIR-21-5P/PPARΑ/FAO Axis. Ding S; Hu Y; Mao P; Lin Q; Yao Z Curr Mol Med; 2024; 24(4):516-523. PubMed ID: 37078352 [TBL] [Abstract][Full Text] [Related]
32. PPARα is essential for retinal lipid metabolism and neuronal survival. Pearsall EA; Cheng R; Zhou K; Takahashi Y; Matlock HG; Vadvalkar SS; Shin Y; Fredrick TW; Gantner ML; Meng S; Fu Z; Gong Y; Kinter M; Humphries KM; Szweda LI; Smith LEH; Ma JX BMC Biol; 2017 Nov; 15(1):113. PubMed ID: 29183319 [TBL] [Abstract][Full Text] [Related]
33. Peroxisomal proliferator-activated receptor α-b deficiency induces the reprogramming of nutrient metabolism in zebrafish. Li LY; Lv HB; Jiang ZY; Qiao F; Chen LQ; Zhang ML; Du ZY J Physiol; 2020 Oct; 598(20):4537-4553. PubMed ID: 32710562 [TBL] [Abstract][Full Text] [Related]
34. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis. Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043 [TBL] [Abstract][Full Text] [Related]
35. GCN5L1 controls renal lipotoxicity through regulating acetylation of fatty acid oxidation enzymes. Lv T; Hu Y; Ma Y; Zhen J; Xin W; Wan Q J Physiol Biochem; 2019 Nov; 75(4):597-606. PubMed ID: 31760589 [TBL] [Abstract][Full Text] [Related]
36. Periostin contributes to renal and cardiac dysfunction in rats with chronic kidney disease: Reduction of PPARα. Bian X; Su X; Wang Y; Zhao G; Zhang B; Li D Biochimie; 2019 May; 160():172-182. PubMed ID: 30890453 [TBL] [Abstract][Full Text] [Related]
37. Branched-Chain Fatty Acids as Mediators of the Activation of Hepatic Peroxisome Proliferator-Activated Receptor Alpha by a Fungal Lipid Extract. Maheshwari G; Ringseis R; Wen G; Gessner DK; Rost J; Fraatz MA; Zorn H; Eder K Biomolecules; 2020 Aug; 10(9):. PubMed ID: 32878262 [TBL] [Abstract][Full Text] [Related]
38. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD. Montagner A; Polizzi A; Fouché E; Ducheix S; Lippi Y; Lasserre F; Barquissau V; Régnier M; Lukowicz C; Benhamed F; Iroz A; Bertrand-Michel J; Al Saati T; Cano P; Mselli-Lakhal L; Mithieux G; Rajas F; Lagarrigue S; Pineau T; Loiseau N; Postic C; Langin D; Wahli W; Guillou H Gut; 2016 Jul; 65(7):1202-14. PubMed ID: 26838599 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of PPAR-alpha activity in mice with cardiac-restricted expression of tumor necrosis factor: potential role of TGF-beta/Smad3. Sekiguchi K; Tian Q; Ishiyama M; Burchfield J; Gao F; Mann DL; Barger PM Am J Physiol Heart Circ Physiol; 2007 Mar; 292(3):H1443-51. PubMed ID: 17098824 [TBL] [Abstract][Full Text] [Related]
40. MicroRNA-21 regulates peroxisome proliferator-activated receptor alpha, a molecular mechanism of cardiac pathology in Cardiorenal Syndrome Type 4. Chuppa S; Liang M; Liu P; Liu Y; Casati MC; Cowley AW; Patullo L; Kriegel AJ Kidney Int; 2018 Feb; 93(2):375-389. PubMed ID: 28760335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]